Neurostyle

Neurostyle operates in the medical-device and rehabilitation categories, with a specialist focus on neurological diagnostics and therapy. Its listed range covers EEG and EMG measurement, intraoperative neuromonitoring, physical therapy, and post-stroke rehabilitation. The nBETTER Stroke Rehabilitation System is a notable point of differentiation in the portfolio: its described approach combines a brain-computer interface, neurofeedback, virtual reality, EEG, and continuous passive motion. The NS-IOM-E extends the range into real-time nerve-function monitoring during surgery. The company is based in Jurong West, Singapore, and its stated distribution reach includes ASEAN and some Middle Eastern countries. Its competitive context is therefore best described by its product mix and regional footprint, not by a verified peer comparison. The profile does not provide market-share, sales, clinical-outcome, or current product-adoption figures, limiting conclusions about its relative scale or commercial standing.

Neurostyle’s trajectory, based on available milestones, is that of a small specialist manufacturer building a portfolio around neurological diagnosis and rehabilitation. The company’s stated ISO 13485 certification and product CE marks in 2013 provide an early indication of attention to medical-device quality and market requirements. Its current listed products span EEG and EMG machines, a portable physical-therapy device, intraoperative neuromonitoring, and the nBETTER post-stroke rehabilitation system, suggesting product development across measurement, monitoring, and therapy rather than a single-device focus. The recorded employee band is 1–10. With no disclosed funding amount or sales and adoption metrics, the evidence supports a cautious assessment: a long-running, focused product-development effort, but an unclear recent growth rate and commercial scale.